Dexcom (DXCM) Income from Continuing Operations (2010 - 2026)
Dexcom (DXCM) posted quarterly Income from Continuing Operations of 249100000.0 for Q2 2026, up 38.54% year-over-year from 179800000.0 in Q2 2025, and up 24.86% quarter-over-quarter from 199500000.0 in Q1 2026.
Dexcom (DXCM) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Income from Continuing Operations for 17 consecutive years, with 249100000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 38.54% year-over-year to 249100000.0; the TTM figure through Jun 2026 stood at 999700000.0 (up 74.93% YoY), while the FY2025 annual figure was 836300000.0, up 45.14% from the prior year.
- Income from Continuing Operations climbed to 249100000.0 in Q2 2026 per DXCM's latest filing, from 199500000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 283800000.0 in Q3 2025 and bottomed at 48600000.0 in Q1 2023.
- Historically, Income from Continuing Operations has averaged 152433333.33 across 5 years, with a median of 139050000.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations jumped 1832.08% — and 2023, when it slumped 50.05%.
- Dexcom's Income from Continuing Operations stood at 91800000.0 in 2022, then soared by 179.19% to 256300000.0 in 2023, then tumbled by 40.81% to 151700000.0 in 2024, then surged by 76.2% to 267300000.0 in 2025, then retreated by 6.81% to 249100000.0 in 2026.
- Business Quant data shows DXCM's Income from Continuing Operations at 249100000.0 in Q2 2026, 199500000.0 in Q1 2026, and 267300000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 249.10 Mn |
| Mar 31, 2026 | 199.50 Mn |
| Dec 31, 2025 | 267.30 Mn |
| Sep 30, 2025 | 283.80 Mn |
| Jun 30, 2025 | 179.80 Mn |
| Mar 31, 2025 | 105.40 Mn |
| Dec 31, 2024 | 151.70 Mn |
| Sep 30, 2024 | 134.60 Mn |
| Jun 30, 2024 | 143.50 Mn |
| Mar 31, 2024 | 146.40 Mn |
| Dec 31, 2023 | 256.30 Mn |
| Sep 30, 2023 | 120.70 Mn |
| Jun 30, 2023 | 115.90 Mn |
| Mar 31, 2023 | 48.60 Mn |
| Dec 31, 2022 | 91.80 Mn |
| Sep 30, 2022 | 101.20 Mn |
| Jun 30, 2022 | 50.90 Mn |
| Mar 31, 2022 | 97.30 Mn |
| Dec 31, 2021 | -5.30 Mn |
| Sep 30, 2021 | 87.30 Mn |